Cirrhosis is the most advanced form of chronic liver disease (CLD), and the 12th most common cause of death globally 1. The global health burden of cirrhosis is expected to increase significantly over ...
Simple FNI labs pinpoint high‑mortality MASLD fibrosis in type 2 diabetes, challenging FIB‑4 and sharpening MASH liver disease screening. An age-independent liver fibrosis marker outperformed 2 widely ...
Liver fibrosis is often undetected whereas it is the determinant of liver-related mortality. We evaluate a pathway based on the systematic calculation of FIB-4 to screen for advanced hepatic fibrosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results